X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Reviving UK-EU Research Collaboration With Horizon Europe

    Developing Pharma Skills With Life Sci For Growth Initiative

    Developing Pharma Skills With Life Sci For Growth Initiative

    Antibiotic Waste Management In Pharmaceutical Manufacturing

    Antibiotic Waste Management In Pharmaceutical Manufacturing

    CDMO Strategies Are Key To Success In The Biopharma Sector

    Rising Demand For CDMOs Amid COVID-19 Reshaping API Market

    Optimizing CDMO Competitiveness Through Pricing Innovation

    Cancer Research Boosts Small Molecule CDMO Market Expansion

    NIH begins study of allergic reactions to Covid-19 vaccines

    Reshaping Parenteral Drug Production Amid COVID Disruption

    Rapid Growth Predicted In The Small Molecule API Market

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Reviving UK-EU Research Collaboration With Horizon Europe

    Developing Pharma Skills With Life Sci For Growth Initiative

    Developing Pharma Skills With Life Sci For Growth Initiative

    Antibiotic Waste Management In Pharmaceutical Manufacturing

    Antibiotic Waste Management In Pharmaceutical Manufacturing

    CDMO Strategies Are Key To Success In The Biopharma Sector

    Rising Demand For CDMOs Amid COVID-19 Reshaping API Market

    Optimizing CDMO Competitiveness Through Pricing Innovation

    Cancer Research Boosts Small Molecule CDMO Market Expansion

    NIH begins study of allergic reactions to Covid-19 vaccines

    Reshaping Parenteral Drug Production Amid COVID Disruption

    Rapid Growth Predicted In The Small Molecule API Market

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development

Reviving UK-EU Research Collaboration With Horizon Europe

Content Team by Content Team
15th September 2023
in Drug Development, News

The United Kingdom has once again become a part of Horizon Europe through a fresh agreement with the European Union. This development opens up opportunities for British scientists to engage in the world’s largest research and development collaboration program. Researchers can now apply for grants and participate in projects with confidence, knowing that the UK will maintain its full associate membership until the agreement concludes in 2027.

In essence, this arrangement allows British companies to collaborate with their European counterparts on research endeavors and provides access to crucial EU funding for research and innovation. Helen Brain, Head of Health and Life Sciences at Square One Law emphasized the significance of this by saying, “[It] will enable British companies to collaborate with their European counterparts on research projects, as well as allowing them to access vital EU research and innovation funding.”

Participation in Horizon Europe also grants access to the €95.5 billion program, as noted by Dr. Benjamin Reid, Programme Director for Innovation at the Confederation of British Industry (CBI). He emphasized that collaboration in research and innovation with the EU is essential for driving long-term sustainable growth and addressing global challenges like climate change.

Janet Valentine, Executive Director for Innovation and Research Policy at the Association of the British Pharmaceutical Industry (ABPI), pointed out that this association revitalizes the long-standing partnership in research and development between the UK and the EU. It directly contributes to the growth and competitiveness of the UK’s life sciences sector, making it an attractive destination for talented researchers.

Additionally, it fosters greater regulatory alignment between the UK and the EU, which benefits exporters and eases the movement of researchers and professionals between the two regions. Helen Brain further explained that the UK’s association with Horizon Europe is expected to create thousands of new job opportunities, aligning with the goal of growing the economy and solidifying the UK’s position as a science and technology leader by 2030.

Recent data released by the BioIndustry Association (BIA) and Clarivate shows that the UK’s life sciences sector has experienced consistent growth in financing activity during Q2 2023. Despite global market challenges, UK-based life science and biotech companies secured £382 million in venture and public financing, marking a 29 percent increase from Q1’s £295 million. This growth was primarily driven by venture capital investments.

Regarding the impact of the UK’s association with Horizon Europe, there is a new automatic clawback mechanism to protect the UK if its scientists receive significantly less funding than the country contributes to the program. This differs from the original terms of association, according to the UK government.

Dr. Tim Bradshaw, Chief Executive of the Russell Group, emphasized that the substantial research supported by Horizon Europe will lead to breakthroughs in medicine, advancements in technologies, and progress in areas such as artificial intelligence (AI).

Previous Post

Rentschler Biopharma UK Site Approved For AAV Production

Related Posts

News

Rentschler Biopharma UK Site Approved For AAV Production

15th September 2023
The New Head Office Tax System For The Cross-Border SMEs
News

The New Head Office Tax System For The Cross-Border SMEs

14th September 2023
News

Over 50% Of FDA-Approved Drugs To Incorporate AI By 2030

14th September 2023
News

Enhancing Gene Therapy Manufacturing, The PAT Project Vision

14th September 2023
News

Drug Portfolio Restrictions Imposed By The FTC On Amgen

14th September 2023
Developing Pharma Skills With Life Sci For Growth Initiative
Drug Development

Developing Pharma Skills With Life Sci For Growth Initiative

14th September 2023

Latest News

Drug Development

Reviving UK-EU Research Collaboration With Horizon Europe

15th September 2023
News

Rentschler Biopharma UK Site Approved For AAV Production

15th September 2023
The New Head Office Tax System For The Cross-Border SMEs
News

The New Head Office Tax System For The Cross-Border SMEs

14th September 2023
News

Over 50% Of FDA-Approved Drugs To Incorporate AI By 2030

14th September 2023
News

Enhancing Gene Therapy Manufacturing, The PAT Project Vision

14th September 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In